Health-tech firm MINISH Technology Inc. announced on October 27 that 22 dentists completed its 15th MINISH Course, the company’s first session for U.S.-based practitioners.
The three-day program took place from October 24 to 26 at the VITA North America training center in Orange County, California, and was officially recognized as a Continuing Education (CE) course for dental professionals.
Despite tuition fees nearly 50% higher than comparable programs, the course sold out rapidly, highlighting strong demand.
The MINISH Course provides both theoretical and practical training in MINISH Veneers, the company’s proprietary tooth restoration solution. The curriculum covers philosophy, tooth preparation, scanning, bonding, occlusion, and veneer placement.
Launched in 2022, the program aims to certify dentists as MINISH Doctors and expand the global network of MINISH Providers. As of October 2025, 342 dentists have completed the course across 15 sessions.
This marked the first time the MINISH Course was held outside Korea. Although MINISH has previously hosted clinical seminars in Tokyo and Beverly Hills, this was the first overseas program offering comprehensive hands-on training.
Many Japanese dentists have preferred traveling to Korea for in-person training, facility tours, and networking with existing MINISH Providers. Between November 2023 and September 2024, three international courses were held in Korea for this purpose.
Graduates may apply to become MINISH Providers after completing clinical proficiency assessments and an on-site facility evaluation.
As of October 2025, there are 75 MINISH Providers worldwide, including 43 in Korea, 29 in Japan, and one each in the U.S., Canada, and Vietnam.
MINISH Technology now offers four international courses annually—two in Japan and two in the United States.
A company representative said, “Hosting our first U.S. program, in the world’s largest healthcare market, is a key milestone in our global expansion.
Extending our presence beyond Asia lays a strong foundation for growth as a global health-tech company.”
